MANHATTAN BRIDGE CAPITAL, INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MANHATTAN BRIDGE CAPITAL, INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	4.65	5.92	7.22	7.34	7.01	6.81	8.57	9.8	9.69	8.67
General and administrative	1.01	1.23	1.32	1.2	1.43	1.35	1.55	1.83	1.78	1.81
Operating income	2.85	3.46	4.2	4.5	4.21	4.41	5.19	5.44	5.57	5.09
Interest expense								2.43	2.25	1.64
Other non-operating income	-0.02				0.02	0.02	0.02
Pre-tax income	2.84	3.44	4.21	4.5	4.23	4.42	5.21	5.48	5.59	5.11
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	2.84	3.44	4.2	4.49	4.23	4.42	5.21	5.48	5.59	5.11
EBITDA	2.86	3.47	4.21	4.5	4.21	4.41	5.2	5.45	5.58	5.1
EPS, basic	0.37	0.42	0.48	0.47	0.44	0.42	0.45	0.48	0.49	0.45
EPS, diluted	0.37	0.42	0.48	0.47	0.44	0.42	0.45	0.48	0.49	0.45
Shares, basic (weighted)	7.59	8.12	8.79	9.66	9.63	10.5	11.5	11.5	11.4	11.4
Shares, diluted (weighted)	7.61	8.13	8.8	9.66	9.63	10.5	11.5	11.5	11.4	11.4

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.1	0.14	0.2	0.12	0.13	0.14	0.1	0.1	0.18	0.2
Receivables									65.4
Other current assets	0.03
Total current assets	28
Property, plant and equipment	0.01
Lease right-of-use assets				0.09	0.37	0.32	0.26	0.21	0.15	0.1
Total assets	35.3	45.9	55.9	54.4	59.8	67.2	76.3	76.4	67.4	62.4
Accounts payable	0.11
Short-term debt									7.23	6.25
Total current liabilities	7.72
Total liabilities	13	23.7	23.8	22.5	27.9	23.8	33.4	33.5	24.1	19.3
Paid-in capital	23.1	23.2	33.1	33.1	33.2	45.5	45.5	45.5	45.6	45.6
Retained earnings	-0.46	-0.39	-0.45	-0.59	-0.4	-1.35	-1.89	-1.57	-1.24	-1.39
Treasury stock	-0.37	-0.54	-0.59	-0.62	-0.8	-0.8	-0.8	-1.06	-1.07	-1.1
Shareholders' equity	22.3	22.2	32.1	31.9	32	43.4	42.9	42.9	43.3	43.1
Total equity	22.3	22.2	32.1	31.9	32	43.4	42.9	42.9	43.3	43.1
Total liabilities and equity	35.3	45.9	55.9	54.4	59.8	67.2	76.3	76.4	67.4	62.4
Shares outstanding	8.14	8.11	9.66	9.66	9.62	11.5	11.5	11.4	11.4	11.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	2.84	3.44	4.2	4.49	4.23	4.42	5.21	5.48	5.59	5.11
Depreciation and amortization	0	0	0	0	0	0	0	0	0	0
Stock-based compensation	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Change in payables	0.01	0.06	0.02	-0.03	0.02	-0.01	0.14	0.01	-0.06	-0.06
Cash from operations	3.05	3.46	4.36	4.43	4.22	4.6	5.17	5.4	4.93	4.93
Capital expenditures	-0	-0	-0		-0.01		-0	-0.01	-0	-0
Cash from investing	-3.85	-10.4	-9.71	1.37	-4.61	-7.62	-8.77	1.64	7.55	5.31
Debt repaid	-1.1
Stock issued				0.02
Dividends paid	-2.7	-3.29	-4	-4.64	-4.14	-4.99	-5.75	-5.31	-5.23	-5.26
Cash from financing	0.79	6.95	5.57	-6.03	0.73	2.7	3.56	-5.45	-14	-10.2
Net change in cash	-0.01	0.04	0.22	-0.24	0.34	-0.32	-0.04	1.59	-1.49	0.03
Free cash flow	3.05	3.46	4.36		4.21		5.16	5.39	4.93	4.93
Interest paid	0.69	1.03	1.58	1.56	1.26	0.98	1.58	2.42	2.32	1.66
Income taxes paid	0	0	0	0	0	0	0	0	0	0

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $3.90 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	58.1%	Operating income / revenue.
EBITDA margin	58.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Net margin	58.3%	Net income / revenue.
Operating cash flow margin	64.0%	Cash from operations / revenue.
Return on equity (ROE)	11.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.4%	Net income / average total assets.
Return on invested capital (ROIC)	8.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.2%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	0.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-10.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-8.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-0.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	3.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-8.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-0.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	3.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-8.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-0.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	3.9%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-8.2%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	0.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	0.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-0.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-1.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	3.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	0.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-1.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	3.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-0.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	0.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	6.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-7.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-6.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	0.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	3.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Liabilities / assets	32.8%	Total liabilities / total assets.
Interest coverage	3.26x	Operating income / interest expense.
Tangible book value	$43.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.13x	Revenue / average total assets.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.42	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$0.71	Revenue / diluted weighted shares.
Operating cash flow per share	$0.46	Cash from operations / diluted weighted shares.
Book value per share	$3.76	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$3.76	Tangible book value / shares outstanding.
Cash per share	$0.02	(Cash + short-term investments) / shares outstanding.
Payout ratio	109.5%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$44.6M	Share price x shares outstanding.
Enterprise value	$44.3M	Market cap + total debt - cash - short-term investments.
P/E	9.38x	Market cap / net income. Only when net income is positive.
P/S	5.47x	Market cap / revenue.
P/B	1.04x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.04x	Market cap / tangible book value, when positive.
P/OCF	8.55x	Market cap / cash from operations, when positive.
EV/Sales	5.44x	Enterprise value / revenue.
EV/EBIT	9.36x	Enterprise value / operating income, when both are positive.
EV/EBITDA	9.36x	Enterprise value / EBITDA, when both are positive.
Earnings yield	10.7%	Net income / market cap (the inverse of P/E).
Dividend yield	11.7%	Dividends paid over the period / market cap.
Shareholder yield	11.7%	(Dividends paid + share buybacks) / market cap.

What was MANHATTAN BRIDGE CAPITAL, INC's revenue in fiscal 2025?

MANHATTAN BRIDGE CAPITAL, INC reported revenue of $8.7M for fiscal 2025, 10.6% lower than the year before.

Was MANHATTAN BRIDGE CAPITAL, INC profitable in fiscal 2025?

Yes. Net income was $5.1M, a net margin of 59%.

How much free cash flow did MANHATTAN BRIDGE CAPITAL, INC generate in fiscal 2025?

Cash from operations of $4.9M minus capital expenditures of $418.0 left free cash flow of $4.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to MANHATTAN BRIDGE CAPITAL, INC